| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | NOLC1 STRN3 DCAF6 IL31RA ANK2 TCOF1 KDM4C BCLAF1 ZMYND8 GON4L ZFPM1 CNTLN SSX5 KMT2D BASP1 ARID5B SMARCA2 MICAL3 PLCB3 CACYBP SPEN NPAT | 8.83e-07 | 1356 | 101 | 22 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator activity | DCAF6 IL31RA KDM4C BCLAF1 ZMYND8 GON4L ZFPM1 SSX5 KMT2D BASP1 ARID5B SMARCA2 SPEN NPAT | 9.02e-07 | 562 | 101 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NOLC1 STRN3 DCAF6 IL31RA ANK2 TCOF1 KDM4C BCLAF1 ZMYND8 GON4L ZFPM1 CNTLN SSX5 KMT2D BASP1 ARID5B SMARCA2 SPEN NPAT | 4.90e-06 | 1160 | 101 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.64e-04 | 229 | 101 | 7 | GO:0003714 | |
| GeneOntologyCellularComponent | fibrillar center | 1.17e-04 | 156 | 102 | 6 | GO:0001650 | |
| Domain | PLC-beta_C | 8.66e-05 | 3 | 101 | 2 | IPR014815 | |
| Domain | PLC-beta_CS | 8.66e-05 | 3 | 101 | 2 | IPR009535 | |
| Domain | DUF1154 | 8.66e-05 | 3 | 101 | 2 | PF06631 | |
| Domain | PLC-beta_C | 8.66e-05 | 3 | 101 | 2 | PF08703 | |
| Domain | PWWP | 1.64e-04 | 20 | 101 | 3 | SM00293 | |
| Domain | FAM47 | 1.73e-04 | 4 | 101 | 2 | PF14642 | |
| Domain | PLC-beta | 1.73e-04 | 4 | 101 | 2 | IPR016280 | |
| Domain | FAM47 | 1.73e-04 | 4 | 101 | 2 | IPR032743 | |
| Domain | EPHD | 2.19e-04 | 22 | 101 | 3 | PS51805 | |
| Domain | PWWP | 2.51e-04 | 23 | 101 | 3 | PF00855 | |
| Domain | PWWP_dom | 2.51e-04 | 23 | 101 | 3 | IPR000313 | |
| Domain | PWWP | 2.86e-04 | 24 | 101 | 3 | PS50812 | |
| Domain | - | 2.86e-04 | 5 | 101 | 2 | 2.40.290.10 | |
| Domain | SPOC-like_C_dom | 2.86e-04 | 5 | 101 | 2 | IPR016194 | |
| Domain | BRK | 4.28e-04 | 6 | 101 | 2 | SM00592 | |
| Domain | BRK_domain | 4.28e-04 | 6 | 101 | 2 | IPR006576 | |
| Domain | BRK | 4.28e-04 | 6 | 101 | 2 | PF07533 | |
| Domain | LisH | 4.56e-04 | 28 | 101 | 3 | SM00667 | |
| Domain | LisH | 4.56e-04 | 28 | 101 | 3 | IPR006594 | |
| Domain | LISH | 4.56e-04 | 28 | 101 | 3 | PS50896 | |
| Domain | DUF3585 | 5.97e-04 | 7 | 101 | 2 | IPR022735 | |
| Domain | DUF3585 | 5.97e-04 | 7 | 101 | 2 | PF12130 | |
| Domain | Bromodomain | 1.13e-03 | 38 | 101 | 3 | PF00439 | |
| Domain | Znf_FYVE_PHD | 1.22e-03 | 147 | 101 | 5 | IPR011011 | |
| Domain | PHD | 1.38e-03 | 89 | 101 | 4 | SM00249 | |
| Domain | SET | 1.41e-03 | 41 | 101 | 3 | PF00856 | |
| Domain | BROMODOMAIN_2 | 1.41e-03 | 41 | 101 | 3 | PS50014 | |
| Domain | Znf_PHD | 1.50e-03 | 91 | 101 | 4 | IPR001965 | |
| Domain | BROMO | 1.51e-03 | 42 | 101 | 3 | SM00297 | |
| Domain | Bromodomain | 1.51e-03 | 42 | 101 | 3 | IPR001487 | |
| Domain | - | 1.51e-03 | 42 | 101 | 3 | 1.20.920.10 | |
| Domain | ZF_PHD_2 | 1.76e-03 | 95 | 101 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.83e-03 | 96 | 101 | 4 | PS01359 | |
| Domain | SET | 1.97e-03 | 46 | 101 | 3 | SM00317 | |
| Domain | SET_dom | 2.50e-03 | 50 | 101 | 3 | IPR001214 | |
| Domain | SET | 2.50e-03 | 50 | 101 | 3 | PS50280 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.90e-03 | 15 | 101 | 2 | IPR001711 | |
| Domain | EF-hand_like | 2.90e-03 | 15 | 101 | 2 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 2.90e-03 | 15 | 101 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 2.90e-03 | 15 | 101 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.90e-03 | 15 | 101 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 2.90e-03 | 15 | 101 | 2 | PF00387 | |
| Domain | PLCYc | 2.90e-03 | 15 | 101 | 2 | SM00149 | |
| Domain | PI-PLC-X | 4.19e-03 | 18 | 101 | 2 | PF00388 | |
| Domain | PLCXc | 4.19e-03 | 18 | 101 | 2 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 4.66e-03 | 19 | 101 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 4.66e-03 | 19 | 101 | 2 | IPR000909 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 STRN3 RAPGEF6 TCOF1 BCLAF1 SAMD4B ZMYND8 ZFPM1 RREB1 PRDM2 SCAF4 MSH6 ZNF106 ZC3H11A KMT2D SMARCA2 FIP1L1 TLN2 MICAL3 PLCB3 SPEN SF3B2 | 1.14e-15 | 774 | 104 | 22 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 TICRR NOP56 TCOF1 BCLAF1 AHCTF1 ZMYND8 SREBF1 RREB1 XRCC5 THOC5 PRDM2 SCAF4 ZNF106 MAP7D1 ZC3H11A PRDM11 KMT2D ARID5B FIP1L1 LAS1L SPEN SF3B2 | 4.23e-12 | 1294 | 104 | 23 | 30804502 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 NOP56 MAP1B TCOF1 BCLAF1 ZMYND8 HECTD4 CHD9 ZCCHC17 XRCC5 MRPS22 THOC5 SCAF4 NEFM MSH6 SLC16A1 FIP1L1 SPEN FKBP3 SF3B2 DYNC1H1 | 8.19e-12 | 1082 | 104 | 21 | 38697112 |
| Pubmed | NOLC1 HYOU1 UNCX BCLAF1 ZMYND8 CHD9 RREB1 PRDM2 SCAF4 MSH6 TXLNA MAP7D1 ZC3H11A KMT2D CLTB SMARCA2 FIP1L1 CACYBP SPEN FKBP3 DYNC1H1 | 1.17e-11 | 1103 | 104 | 21 | 34189442 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 STRN3 RAPGEF6 ANK2 NOP56 MAP1B TCOF1 BCLAF1 AHCTF1 ZMYND8 FAM114A2 XRCC5 SCAF4 MSH6 ZC3H11A CACYBP FKBP3 SF3B2 AHNAK2 | 4.15e-11 | 934 | 104 | 19 | 33916271 |
| Pubmed | HYOU1 NOP56 TCOF1 SPCS1 TOM1 SMG5 XRCC5 MRPS22 THOC5 SCAF4 MSH6 ZNF106 BASP1 SMARCA2 CACYBP LAS1L | 7.43e-11 | 634 | 104 | 16 | 34591612 | |
| Pubmed | RAPGEF6 NOP56 MAP1B TCOF1 BCLAF1 AHCTF1 SCAF4 NEFM MSH6 ZC3H11A KMT2D SLC16A1 CACYBP SPEN DYNC1H1 | 1.02e-10 | 549 | 104 | 15 | 38280479 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | STRN3 HYOU1 NOP56 MAP1B TCOF1 TOM1 XRCC5 MRPS22 SCAF4 NEFM MSH6 MAP7D1 BASP1 CLTB FIP1L1 MICAL3 CACYBP FKBP3 SF3B2 DYNC1H1 | 1.87e-10 | 1149 | 104 | 20 | 35446349 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | NOLC1 STRN3 HYOU1 NOP56 TCOF1 BCLAF1 PPFIBP1 SAMD4B CNKSR2 BCAS1 MRPS22 AZIN1 MALT1 MSH6 TXLNA MAP7D1 SLC16A1 CACYBP LAS1L SF3B2 DYNC1H1 | 1.91e-10 | 1284 | 104 | 21 | 17353931 |
| Pubmed | NOLC1 NOP56 ZMYND8 GON4L SMG5 RREB1 XRCC5 MRPS22 PRDM2 SCAF4 MAP7D1 KMT2D BASP1 ARID5B SMARCA2 FIP1L1 USP54 CACYBP LAS1L SPEN DYNC1H1 NPAT | 2.07e-10 | 1429 | 104 | 22 | 35140242 | |
| Pubmed | ANK2 NOP56 TCOF1 BCLAF1 AHCTF1 DAB1 ZCCHC17 HM13 XRCC5 THOC5 SCAF4 TXLNA MAP7D1 ARHGEF40 CLTB FIP1L1 CCDC106 LAS1L FKBP3 SF3B2 DYNC1H1 | 6.25e-10 | 1371 | 104 | 21 | 36244648 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 HYOU1 NOP56 BCLAF1 PPFIBP1 AHCTF1 XRCC5 MRPS22 THOC5 MSH6 TXLNA MAP7D1 ZC3H11A SLC16A1 CACYBP LAS1L SPEN FKBP3 SF3B2 DYNC1H1 | 8.88e-10 | 1257 | 104 | 20 | 36526897 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | STRN3 TCOF1 BCLAF1 AGGF1 CNTLN XRCC5 MRPS22 THOC5 SCAF4 FIP1L1 MICAL3 CACYBP LAS1L FKBP3 DYNC1H1 | 1.57e-09 | 670 | 104 | 15 | 22990118 |
| Pubmed | NOP56 MAP1B TCOF1 ZMYND8 CHD9 XRCC5 MRPS22 MSH6 TXLNA ZC3H11A SLC16A1 CLTB CACYBP FKBP3 SF3B2 DYNC1H1 | 2.51e-09 | 809 | 104 | 16 | 32129710 | |
| Pubmed | HYOU1 ANK2 NOP56 MAP1B TCOF1 BCLAF1 PPFIBP1 AHCTF1 HM13 XRCC5 SLC16A1 MICAL3 CACYBP SF3B2 DYNC1H1 | 3.30e-09 | 708 | 104 | 15 | 39231216 | |
| Pubmed | 3.39e-09 | 177 | 104 | 9 | 26206133 | ||
| Pubmed | NOLC1 STRN3 TCOF1 BCLAF1 AHCTF1 SAMD4B RRM2 MSH6 ZC3H11A FIP1L1 TLN2 LAS1L SPEN | 3.84e-09 | 503 | 104 | 13 | 16964243 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HYOU1 NOP56 MAP1B BCLAF1 SMG5 THOC5 TXLNA MAP7D1 BASP1 FIP1L1 CACYBP LAS1L SPEN FKBP3 AHNAK2 | 4.45e-09 | 724 | 104 | 15 | 36232890 |
| Pubmed | NOLC1 BRPF3 DCAF6 TCOF1 AHCTF1 ZMYND8 CHD9 CLSTN2 RREB1 MALT1 MSH6 MAP7D1 ARHGEF40 SLC16A1 PRPF40B SMARCA2 FIP1L1 USP54 | 5.58e-09 | 1116 | 104 | 18 | 31753913 | |
| Pubmed | NOLC1 HYOU1 MAP1B TCOF1 AHCTF1 XRCC5 NEFM MSH6 ZC3H11A SMARCA2 LAS1L SPEN SF3B2 DYNC1H1 | 9.92e-09 | 653 | 104 | 14 | 22586326 | |
| Pubmed | NOLC1 HYOU1 ANK2 NOP56 TCOF1 TEX2 BCLAF1 PPFIBP1 AHCTF1 HM13 XRCC5 MRPS22 THOC5 TXLNA SLC16A1 BASP1 CACYBP LAS1L SF3B2 NPAT | 1.52e-08 | 1487 | 104 | 20 | 33957083 | |
| Pubmed | STRN3 PPFIBP1 PPP1R12B AHCTF1 SAMD4B TOM1 ZMYND8 GON4L MRPS22 CEP164 C6orf132 SCAF4 MSH6 MAP7D1 ZC3H11A MICALL2 SMARCA2 LAS1L SPEN FKBP3 | 1.70e-08 | 1497 | 104 | 20 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 NOP56 MAP1B BCLAF1 AHCTF1 ZMYND8 RREB1 XRCC5 SCAF4 ZC3H11A FIP1L1 LAS1L SPEN FKBP3 SF3B2 NPAT | 2.52e-08 | 954 | 104 | 16 | 36373674 |
| Pubmed | STRN3 ANK2 NOP56 TCOF1 BCLAF1 HECTD4 CNKSR2 XRCC5 NEFM TXLNA MAP7D1 BASP1 PLCB1 TLN2 EML1 DYNC1H1 | 2.87e-08 | 963 | 104 | 16 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 RAPGEF6 MAP1B TEX2 PPFIBP1 SAMD4B RRM2 C6orf132 ZNF106 MAP7D1 SLC16A1 FIP1L1 USP54 FGD6 AHNAK2 | 4.39e-08 | 861 | 104 | 15 | 36931259 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | TICRR MAP1B TCOF1 MRPS22 THOC5 ZNF106 MAP7D1 KMT2D SMARCA2 FIP1L1 SPEN | 4.47e-08 | 410 | 104 | 11 | 26949251 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NOLC1 STRN3 DCAF6 NOP56 BCLAF1 PPP1R12B AHCTF1 AGGF1 MRPS22 ZNF106 MAP7D1 MICALL2 SMARCA2 TLN2 MICAL3 SF3B2 DYNC1H1 | 5.85e-08 | 1155 | 104 | 17 | 20360068 |
| Pubmed | RAPGEF6 HYOU1 MAP1B PPFIBP1 SAMD4B SREBF1 GON4L TXLNA MAP7D1 ARHGEF40 MICAL3 PLCB3 SF3B2 | 7.78e-08 | 650 | 104 | 13 | 38777146 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | TCOF1 BCLAF1 HECTD4 XRCC5 RRM2 MSH6 SMARCA2 FIP1L1 USP54 CACYBP LAS1L | 9.11e-08 | 440 | 104 | 11 | 34244565 |
| Pubmed | ANK2 MAP1B TEX2 CNKSR2 BCAS1 NEFM SLC16A1 BASP1 PLCB1 MICAL3 | 9.77e-08 | 347 | 104 | 10 | 17114649 | |
| Pubmed | NOLC1 HYOU1 NOP56 BCLAF1 XRCC5 MRPS22 NEFM SLC16A1 BASP1 CLTB FIP1L1 CACYBP SPINDOC DYNC1H1 | 9.83e-08 | 786 | 104 | 14 | 29128334 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 NOP56 TCOF1 BCLAF1 SAMD4B ZCCHC17 XRCC5 SCAF4 ZC3H11A FIP1L1 LAS1L SPEN SF3B2 DYNC1H1 | 1.36e-07 | 807 | 104 | 14 | 22681889 |
| Pubmed | TCOF1 BCLAF1 PPFIBP1 SCAF4 SNCAIP CLTB MICAL3 SF3B2 DYNC1H1 AHNAK2 | 1.37e-07 | 360 | 104 | 10 | 33111431 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 NOP56 TCOF1 BCLAF1 PPP1R12B AHCTF1 ZCCHC17 XRCC5 SLC16A1 BASP1 CLTB FIP1L1 LAS1L SF3B2 DYNC1H1 | 1.54e-07 | 949 | 104 | 15 | 36574265 |
| Pubmed | 1.87e-07 | 282 | 104 | 9 | 23667531 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.93e-07 | 283 | 104 | 9 | 30585729 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 HYOU1 NOP56 TCOF1 PPFIBP1 XRCC5 MRPS22 MSH6 TXLNA MAP7D1 SLC16A1 BASP1 PLCB3 CACYBP FKBP3 SF3B2 DYNC1H1 AHNAK2 | 2.01e-07 | 1415 | 104 | 18 | 28515276 |
| Pubmed | 2.15e-07 | 44 | 104 | 5 | 38351062 | ||
| Pubmed | DCAF6 RAPGEF6 PPFIBP1 SLC16A1 ARID5B MICAL3 PLCB3 CACYBP SPINDOC AHNAK2 | 2.15e-07 | 378 | 104 | 10 | 34315543 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.30e-07 | 289 | 104 | 9 | 23752268 | |
| Pubmed | DCAF6 ANK2 TCOF1 KDM4C PPFIBP1 ZMYND8 HECTD4 CHD9 SMG5 NEFM ARID5B FIP1L1 TLN2 ANKRD36 USP54 SF3B2 DYNC1H1 | 2.65e-07 | 1285 | 104 | 17 | 35914814 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 NOP56 TCOF1 BCLAF1 ZMYND8 XRCC5 MSH6 SMARCA2 FIP1L1 LAS1L SPEN SF3B2 | 2.78e-07 | 605 | 104 | 12 | 28977666 |
| Pubmed | NOLC1 NOP56 TCOF1 BCLAF1 XRCC5 MRPS22 THOC5 ZC3H11A SLC16A1 FIP1L1 TLN2 SPEN SF3B2 | 2.97e-07 | 731 | 104 | 13 | 29298432 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.30e-07 | 148 | 104 | 7 | 32538781 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 HYOU1 NOP56 TCOF1 AHCTF1 ZMYND8 ZCCHC17 RREB1 XRCC5 MRPS22 MSH6 SLC16A1 SMARCA2 CACYBP LAS1L SF3B2 DYNC1H1 | 3.78e-07 | 1318 | 104 | 17 | 30463901 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 TICRR NOP56 MAP1B AGGF1 ZCCHC17 XRCC5 MRPS22 MSH6 TXLNA ZC3H11A LAS1L FKBP3 | 4.54e-07 | 759 | 104 | 13 | 35915203 |
| Pubmed | 4.71e-07 | 156 | 104 | 7 | 37108203 | ||
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 4.99e-07 | 317 | 104 | 9 | 17620599 | |
| Pubmed | RAPGEF6 ZMYND8 RREB1 PRDM2 NEFM MAP7D1 KMT2D SLC16A1 ARID5B NPAT | 5.40e-07 | 418 | 104 | 10 | 34709266 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 NOP56 MAP1B AHCTF1 XRCC5 RRM2 MSH6 MAP7D1 ZC3H11A ARHGEF40 SLC16A1 SMARCA2 FIP1L1 LAS1L SF3B2 DYNC1H1 AHNAK2 | 5.43e-07 | 1353 | 104 | 17 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NOLC1 HYOU1 MAP1B TCOF1 BCLAF1 TOM1 FAM114A2 XRCC5 MRPS22 MSH6 ZC3H11A SLC16A1 SMARCA2 CACYBP FKBP3 SF3B2 AHNAK2 | 6.26e-07 | 1367 | 104 | 17 | 32687490 |
| Pubmed | NOLC1 TICRR NAALAD2 ANK2 NOP56 GON4L ZCCHC17 THOC5 AZIN1 PRPF40B BASP1 CLTB MICAL3 PLCB3 USP54 FKBP3 | 6.59e-07 | 1215 | 104 | 16 | 15146197 | |
| Pubmed | 6.99e-07 | 103 | 104 | 6 | 32744500 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 7.33e-07 | 332 | 104 | 9 | 32786267 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 9.14e-07 | 341 | 104 | 9 | 32971831 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 HECTD4 SREBF1 GBX2 SMG5 ZFPM1 C6orf132 ZC3H11A ARHGEF40 KMT2D TLN2 MICAL3 SPEN DYNC1H1 AHNAK2 | 1.05e-06 | 1105 | 104 | 15 | 35748872 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 HYOU1 NOP56 TCOF1 BCLAF1 XRCC5 PRDM2 MSH6 TXLNA ZC3H11A SLC16A1 TLN2 CACYBP SPEN FKBP3 SF3B2 DYNC1H1 | 1.11e-06 | 1425 | 104 | 17 | 30948266 |
| Pubmed | NOLC1 HYOU1 NOP56 MAP1B BCLAF1 PPFIBP1 TOM1 XRCC5 MRPS22 MSH6 MAP7D1 BASP1 CLTB MICAL3 LAS1L DYNC1H1 AHNAK2 | 1.28e-06 | 1440 | 104 | 17 | 30833792 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | HYOU1 NOP56 MAP1B BCLAF1 XRCC5 RRM2 MRPS22 MAP7D1 ZC3H11A LAS1L SF3B2 DYNC1H1 | 1.58e-06 | 714 | 104 | 12 | 28302793 |
| Pubmed | 1.81e-06 | 67 | 104 | 5 | 29254152 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 HYOU1 NOP56 MAP1B TCOF1 BCLAF1 XRCC5 SCAF4 ZC3H11A FIP1L1 LAS1L SPEN SF3B2 DYNC1H1 | 2.29e-06 | 1024 | 104 | 14 | 24711643 |
| Pubmed | 3.85e-06 | 78 | 104 | 5 | 28611094 | ||
| Pubmed | STRN3 HYOU1 ANK2 MAP1B BCLAF1 PPP1R12B TOM1 CNKSR2 BCAS1 MRPS22 NEFM MAP7D1 TLN2 MICAL3 USP54 DYNC1H1 | 5.42e-06 | 1431 | 104 | 16 | 37142655 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 7.05e-06 | 330 | 104 | 8 | 33301849 | |
| Pubmed | NOLC1 STRN3 ANK2 MAP1B TEX2 BCLAF1 CNKSR2 HM13 SLC16A1 BASP1 CLTB PLCB1 TLN2 CACYBP | 7.72e-06 | 1139 | 104 | 14 | 36417873 | |
| Pubmed | 8.51e-06 | 43 | 104 | 4 | 36950384 | ||
| Pubmed | 8.58e-06 | 339 | 104 | 8 | 30415952 | ||
| Pubmed | 8.76e-06 | 340 | 104 | 8 | 29478914 | ||
| Pubmed | Ku86 is important for TrkA overexpression-induced breast cancer cell invasion. | 8.86e-06 | 2 | 104 | 2 | 21137076 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | STRN3 HYOU1 NOP56 MAP1B PPP1R12B CNTLN XRCC5 LAS1L SF3B2 DYNC1H1 | 8.89e-06 | 573 | 104 | 10 | 28330616 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | NOP56 BCLAF1 XRCC5 MRPS22 SCAF4 NEFM MSH6 TXLNA SMARCA2 TLN2 SF3B2 DYNC1H1 | 8.97e-06 | 847 | 104 | 12 | 35235311 |
| Pubmed | NOP56 TCOF1 BCLAF1 AHCTF1 ZMYND8 XRCC5 MRPS22 ZC3H11A BASP1 FIP1L1 LAS1L SF3B2 | 8.97e-06 | 847 | 104 | 12 | 35850772 | |
| Pubmed | Cell-fate determination by ubiquitin-dependent regulation of translation. | 9.23e-06 | 14 | 104 | 3 | 26399832 | |
| Pubmed | HYOU1 BCLAF1 AHCTF1 HM13 XRCC5 MAP7D1 KMT2D FIP1L1 FKBP3 SF3B2 DYNC1H1 | 9.62e-06 | 711 | 104 | 11 | 33022573 | |
| Pubmed | NOP56 BCLAF1 SAMD4B MRPS22 THOC5 SCAF4 MSH6 MAP7D1 ZC3H11A FIP1L1 SF3B2 | 9.87e-06 | 713 | 104 | 11 | 29802200 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.00e-05 | 163 | 104 | 6 | 22113938 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MAP1B ZMYND8 AGGF1 SMG5 NEFM MAP7D1 ZC3H11A KMT2D FIP1L1 SPEN SF3B2 DYNC1H1 | 1.01e-05 | 857 | 104 | 12 | 25609649 |
| Pubmed | NOLC1 BCLAF1 ZMYND8 CHD9 XRCC5 THOC5 MSH6 ZC3H11A SMARCA2 FIP1L1 CACYBP FKBP3 SF3B2 | 1.08e-05 | 1014 | 104 | 13 | 32416067 | |
| Pubmed | 1.10e-05 | 251 | 104 | 7 | 31076518 | ||
| Pubmed | 1.10e-05 | 251 | 104 | 7 | 27507650 | ||
| Pubmed | 1.22e-05 | 255 | 104 | 7 | 15324660 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.25e-05 | 256 | 104 | 7 | 33397691 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.25e-05 | 256 | 104 | 7 | 32698014 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.27e-05 | 358 | 104 | 8 | 32460013 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAM47A TICRR BRME1 AMER3 XRCC5 PRDM2 MSH6 BASP1 ARID5B PLCB3 DYNC1H1 | 1.33e-05 | 736 | 104 | 11 | 29676528 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.35e-05 | 259 | 104 | 7 | 30404004 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.35e-05 | 361 | 104 | 8 | 26167880 | |
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 1.97e-05 | 53 | 104 | 4 | 15572359 | |
| Pubmed | NOLC1 TCOF1 BCLAF1 PPFIBP1 ZCCHC17 CNKSR2 ZC3H11A BASP1 FIP1L1 SPEN DYNC1H1 | 2.18e-05 | 777 | 104 | 11 | 35844135 | |
| Pubmed | 2.20e-05 | 506 | 104 | 9 | 30890647 | ||
| Pubmed | 2.46e-05 | 114 | 104 | 5 | 31553912 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 11581286 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 15042714 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 8687404 | ||
| Pubmed | Gene mapping in a murine cell line by immunoselection with cytotoxic T lymphocytes. | 2.65e-05 | 3 | 104 | 2 | 7514566 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 32722282 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 27749841 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 36527595 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 15604408 | ||
| Pubmed | A conserved interaction that is essential for the biogenesis of histone locus bodies. | 2.65e-05 | 3 | 104 | 2 | 25339177 | |
| Interaction | CEBPA interactions | NOLC1 HYOU1 NOP56 UNCX BCLAF1 ZMYND8 CHD9 RREB1 XRCC5 THOC5 PRDM2 SCAF4 MSH6 TXLNA MAP7D1 ZC3H11A KMT2D CLTB SMARCA2 FIP1L1 CACYBP SPEN FKBP3 DYNC1H1 | 1.50e-08 | 1245 | 104 | 24 | int:CEBPA |
| Interaction | KCNA3 interactions | HYOU1 ANK2 NOP56 MAP1B TCOF1 BCLAF1 PPFIBP1 AHCTF1 CHD9 HM13 XRCC5 PRDM2 SLC16A1 TLN2 MICAL3 CACYBP SPEN SF3B2 DYNC1H1 | 9.19e-08 | 871 | 104 | 19 | int:KCNA3 |
| Interaction | MECP2 interactions | NOLC1 NOP56 MAP1B TCOF1 BCLAF1 ZMYND8 HECTD4 CHD9 ZCCHC17 XRCC5 MRPS22 THOC5 SCAF4 NEFM MSH6 SLC16A1 PRPF40B SMARCA2 FIP1L1 SPEN FKBP3 SF3B2 DYNC1H1 | 1.26e-07 | 1287 | 104 | 23 | int:MECP2 |
| Interaction | YAP1 interactions | RAPGEF6 HYOU1 NOP56 TCOF1 BCLAF1 AHCTF1 TOM1 CNKSR2 XRCC5 SCAF4 NEFM MSH6 ZC3H11A KMT2D SLC16A1 SMARCA2 CACYBP SPINDOC SPEN SF3B2 DYNC1H1 | 1.54e-07 | 1095 | 104 | 21 | int:YAP1 |
| Interaction | HDAC1 interactions | NOLC1 RAPGEF6 KDM4C ZMYND8 SREBF1 GON4L ZFPM1 RREB1 THOC5 NEFM ZNF750 MSH6 MAP7D1 KMT2D SLC16A1 ARID5B SMARCA2 SPEN FKBP3 SF3B2 NPAT | 1.88e-07 | 1108 | 104 | 21 | int:HDAC1 |
| Interaction | KDM1A interactions | RAPGEF6 KDM4C NTRK1 ZMYND8 ZCCHC17 ZFPM1 RREB1 PRDM2 NEFM ZNF750 MALT1 MSH6 MAP7D1 KMT2D SLC16A1 ARID5B SMARCA2 SF3B2 NPAT | 3.03e-07 | 941 | 104 | 19 | int:KDM1A |
| Interaction | CSNK2A1 interactions | NOLC1 NOP56 TCOF1 BCLAF1 NTRK1 ZMYND8 ZCCHC17 CNKSR2 XRCC5 THOC5 MSH6 SNCAIP CLTB FIP1L1 CCDC106 ANKRD36 USP54 FKBP3 SF3B2 | 3.86e-07 | 956 | 104 | 19 | int:CSNK2A1 |
| Interaction | NAA40 interactions | NOLC1 STRN3 RAPGEF6 ANK2 NOP56 MAP1B TCOF1 BCLAF1 AHCTF1 ZMYND8 FAM114A2 XRCC5 SCAF4 MSH6 ZC3H11A CACYBP FKBP3 SF3B2 AHNAK2 | 5.45e-07 | 978 | 104 | 19 | int:NAA40 |
| Interaction | NUP43 interactions | NOP56 BCLAF1 AHCTF1 ZMYND8 GON4L CHD9 CLSTN2 RRM2 PRDM2 CD93 KMT2D LAS1L SPEN AHNAK2 NPAT | 7.43e-07 | 625 | 104 | 15 | int:NUP43 |
| Interaction | CSNK2A2 interactions | NOLC1 BRPF3 TCOF1 BCLAF1 NTRK1 ZMYND8 ZCCHC17 ZNF106 CLTB FIP1L1 CCDC106 ANKRD36 LAS1L FKBP3 SF3B2 AHNAK2 | 8.16e-07 | 718 | 104 | 16 | int:CSNK2A2 |
| Interaction | CEBPB interactions | NOLC1 TICRR HYOU1 NOP56 TCOF1 BCLAF1 AHCTF1 XRCC5 RRM2 MRPS22 THOC5 SCAF4 MSH6 TXLNA ZC3H11A KMT2D SMARCA2 FIP1L1 CACYBP LAS1L FKBP3 SF3B2 DYNC1H1 | 9.49e-07 | 1443 | 104 | 23 | int:CEBPB |
| Interaction | SUPT5H interactions | NOLC1 DCAF6 NOP56 BCLAF1 NTRK1 XRCC5 SCAF4 MSH6 ZNF106 KMT2D SPEN NPAT | 1.30e-06 | 408 | 104 | 12 | int:SUPT5H |
| Interaction | YWHAH interactions | NOLC1 TICRR RAPGEF6 TEX2 PPFIBP1 NTRK1 SAMD4B HECTD4 RRM2 PTH1R C6orf132 ZNF106 MAP7D1 SNCAIP SLC16A1 BASP1 USP54 FGD6 AHNAK2 | 3.20e-06 | 1102 | 104 | 19 | int:YWHAH |
| Interaction | SNCA interactions | NOP56 MAP1B AHCTF1 RREB1 MRPS22 NEFM MSH6 ZC3H11A SNCAIP BASP1 PLCB1 TLN2 CACYBP FKBP3 DYNC1H1 | 3.97e-06 | 716 | 104 | 15 | int:SNCA |
| Interaction | MYCN interactions | NOLC1 BRPF3 NOP56 MAP1B TCOF1 BCLAF1 ZMYND8 ZCCHC17 XRCC5 MRPS22 THOC5 NEFM ZNF106 MAP7D1 ZC3H11A SLC16A1 CLTB SMARCA2 FIP1L1 CACYBP SF3B2 | 5.89e-06 | 1373 | 104 | 21 | int:MYCN |
| Interaction | SIRT7 interactions | NOLC1 HYOU1 NOP56 MAP1B TCOF1 AHCTF1 XRCC5 NEFM MSH6 ZC3H11A SMARCA2 LAS1L SPEN SF3B2 DYNC1H1 | 6.30e-06 | 744 | 104 | 15 | int:SIRT7 |
| Interaction | CUL7 interactions | NOLC1 BRPF3 HYOU1 NOP56 MAP1B TCOF1 BCLAF1 XRCC5 MSH6 ZC3H11A FIP1L1 PLCB3 LAS1L SPEN SF3B2 DYNC1H1 | 6.64e-06 | 845 | 104 | 16 | int:CUL7 |
| Interaction | DDX23 interactions | NOLC1 NOP56 MAP1B TCOF1 BCLAF1 NTRK1 CEP164 THOC5 NEFM MSH6 FIP1L1 LAS1L | 6.91e-06 | 480 | 104 | 12 | int:DDX23 |
| Interaction | RCOR1 interactions | RAPGEF6 ZMYND8 RREB1 NEFM ZNF750 MSH6 MAP7D1 KMT2D SLC16A1 ARID5B SPEN NPAT | 9.22e-06 | 494 | 104 | 12 | int:RCOR1 |
| Interaction | BAP1 interactions | STRN3 HYOU1 NOP56 MAP1B TCOF1 TOM1 XRCC5 MRPS22 SCAF4 NEFM MSH6 MAP7D1 BASP1 CLTB FIP1L1 MICAL3 CACYBP FKBP3 SF3B2 DYNC1H1 | 1.10e-05 | 1314 | 104 | 20 | int:BAP1 |
| Interaction | SNX27 interactions | DCAF6 RAPGEF6 PPFIBP1 NTRK1 SLC16A1 SPANXN4 ARID5B MICAL3 PLCB3 CACYBP SPINDOC AHNAK2 | 1.24e-05 | 509 | 104 | 12 | int:SNX27 |
| Interaction | H3C1 interactions | ANK2 KDM4C AHCTF1 ZMYND8 XRCC5 MRPS22 PRDM2 MSH6 MAP7D1 KMT2D MICALL2 BASP1 SMARCA2 SPEN SF3B2 DYNC1H1 | 1.48e-05 | 901 | 104 | 16 | int:H3C1 |
| Interaction | PYHIN1 interactions | MAP1B TCOF1 RREB1 XRCC5 MRPS22 SLC16A1 CACYBP LAS1L SPEN SF3B2 | 1.64e-05 | 358 | 104 | 10 | int:PYHIN1 |
| Interaction | HTATSF1 interactions | 1.72e-05 | 157 | 104 | 7 | int:HTATSF1 | |
| Interaction | CSNK2B interactions | NOLC1 TCOF1 BCLAF1 NTRK1 ZMYND8 ZCCHC17 ZNF106 SNCAIP CCDC106 MICAL3 FKBP3 SF3B2 DYNC1H1 | 1.99e-05 | 625 | 104 | 13 | int:CSNK2B |
| Interaction | SMURF1 interactions | DCAF6 MAP1B TCOF1 BCLAF1 TOM1 SREBF1 XRCC5 MRPS22 NEFM EML1 FKBP3 SF3B2 | 2.40e-05 | 544 | 104 | 12 | int:SMURF1 |
| Interaction | KIF20A interactions | NOLC1 BRPF3 ANK2 NOP56 BCLAF1 PPFIBP1 AHCTF1 HECTD4 XRCC5 NEFM ZNF106 BASP1 SMARCA2 FIP1L1 USP54 SF3B2 AHNAK2 | 2.61e-05 | 1052 | 104 | 17 | int:KIF20A |
| Interaction | MKI67 interactions | TICRR NOP56 MAP1B TCOF1 MRPS22 THOC5 ZNF106 MAP7D1 ZC3H11A KMT2D SMARCA2 FIP1L1 SPEN | 2.91e-05 | 648 | 104 | 13 | int:MKI67 |
| Interaction | CAMKV interactions | 3.37e-05 | 118 | 104 | 6 | int:CAMKV | |
| Interaction | EED interactions | NOLC1 HYOU1 NOP56 MAP1B TCOF1 BCLAF1 AHCTF1 TOM1 ZCCHC17 XRCC5 PRDM2 SCAF4 MSH6 ZC3H11A SLC16A1 SMARCA2 CACYBP LAS1L SPEN DYNC1H1 | 4.31e-05 | 1445 | 104 | 20 | int:EED |
| Interaction | DHX40 interactions | 4.50e-05 | 249 | 104 | 8 | int:DHX40 | |
| Interaction | ASF1A interactions | 4.50e-05 | 249 | 104 | 8 | int:ASF1A | |
| Interaction | BARD1 interactions | 4.52e-05 | 323 | 104 | 9 | int:BARD1 | |
| Interaction | ECT2 interactions | NOLC1 NOP56 TCOF1 BCLAF1 AGGF1 XRCC5 MRPS22 CEP164 BASP1 MICAL3 CACYBP LAS1L SF3B2 DYNC1H1 AHNAK2 | 4.92e-05 | 887 | 104 | 15 | int:ECT2 |
| Interaction | SMC5 interactions | NOLC1 NOP56 MAP1B BCLAF1 AHCTF1 ZMYND8 RREB1 XRCC5 SCAF4 ZC3H11A FIP1L1 LAS1L SPEN FKBP3 SF3B2 NPAT | 5.21e-05 | 1000 | 104 | 16 | int:SMC5 |
| Interaction | TOP3B interactions | RAPGEF6 HYOU1 SAMD4B HECTD4 SREBF1 GBX2 SMG5 ZFPM1 XRCC5 RRM2 C6orf132 ZC3H11A ARHGEF40 KMT2D TLN2 MICAL3 SPEN FKBP3 DYNC1H1 AHNAK2 | 5.48e-05 | 1470 | 104 | 20 | int:TOP3B |
| Interaction | OBSL1 interactions | NOLC1 NOP56 TCOF1 BCLAF1 PPFIBP1 XRCC5 SCAF4 MAP7D1 ZC3H11A PRDM11 FIP1L1 LAS1L SPEN SF3B2 DYNC1H1 | 5.94e-05 | 902 | 104 | 15 | int:OBSL1 |
| Interaction | H2BC21 interactions | TICRR BRPF3 MAP1B BCLAF1 AHCTF1 ZMYND8 SMG5 RREB1 XRCC5 PRDM2 SCAF4 MSH6 DYNC1H1 | 6.05e-05 | 696 | 104 | 13 | int:H2BC21 |
| Interaction | YWHAB interactions | TICRR RAPGEF6 PPFIBP1 NTRK1 SAMD4B HECTD4 CNTLN XRCC5 C6orf132 ZNF106 MAP7D1 BASP1 USP54 FGD6 DYNC1H1 AHNAK2 | 6.15e-05 | 1014 | 104 | 16 | int:YWHAB |
| Interaction | PFN1 interactions | STRN3 RAPGEF6 ANK2 TEX2 NTRK1 C6orf132 BASP1 MICAL3 FKBP3 SF3B2 AHNAK2 | 6.43e-05 | 509 | 104 | 11 | int:PFN1 |
| Interaction | YWHAG interactions | NOLC1 TICRR RAPGEF6 BCLAF1 PPFIBP1 NTRK1 SAMD4B HECTD4 CNTLN RRM2 C6orf132 ZNF106 MAP7D1 FIP1L1 USP54 FGD6 DYNC1H1 AHNAK2 | 6.52e-05 | 1248 | 104 | 18 | int:YWHAG |
| Interaction | KLF16 interactions | NOLC1 NOP56 GON4L RREB1 MRPS22 THOC5 MAP7D1 KMT2D LAS1L NPAT | 6.99e-05 | 425 | 104 | 10 | int:KLF16 |
| Interaction | PHF21A interactions | 7.17e-05 | 343 | 104 | 9 | int:PHF21A | |
| Interaction | SNRPB interactions | BCLAF1 DAB1 MRPS22 THOC5 SCAF4 ZC3H11A MICAL3 USP54 CACYBP SF3B2 DYNC1H1 | 7.39e-05 | 517 | 104 | 11 | int:SNRPB |
| Interaction | ASB3 interactions | 7.42e-05 | 84 | 104 | 5 | int:ASB3 | |
| Interaction | OFD1 interactions | 7.83e-05 | 347 | 104 | 9 | int:OFD1 | |
| Interaction | USP53 interactions | 8.09e-05 | 138 | 104 | 6 | int:USP53 | |
| Interaction | APEX1 interactions | NOLC1 RAPGEF6 NOP56 TCOF1 KDM4C NTRK1 AHCTF1 ZMYND8 CHD9 RREB1 XRCC5 MRPS22 PRDM2 MALT1 MAP7D1 BASP1 PLCB1 LAS1L | 8.24e-05 | 1271 | 104 | 18 | int:APEX1 |
| Interaction | CDX2 interactions | 8.30e-05 | 86 | 104 | 5 | int:CDX2 | |
| Interaction | CHD4 interactions | NOLC1 DCAF6 NOP56 TCOF1 BCLAF1 NTRK1 ZMYND8 GBX2 XRCC5 MSH6 SMARCA2 FIP1L1 LAS1L SPEN SF3B2 | 9.21e-05 | 938 | 104 | 15 | int:CHD4 |
| Interaction | SIRT6 interactions | TCOF1 BCLAF1 HECTD4 XRCC5 RRM2 MSH6 TXLNA SMARCA2 FIP1L1 USP54 CACYBP LAS1L | 9.56e-05 | 628 | 104 | 12 | int:SIRT6 |
| Interaction | ZBTB2 interactions | NOLC1 BRPF3 NOP56 BCLAF1 ZMYND8 MRPS22 MSH6 LAS1L FKBP3 SF3B2 | 1.12e-04 | 450 | 104 | 10 | int:ZBTB2 |
| Interaction | FMNL3 interactions | 1.19e-04 | 49 | 104 | 4 | int:FMNL3 | |
| Interaction | CIT interactions | NOLC1 NOP56 TCOF1 BCLAF1 AHCTF1 ZMYND8 RREB1 XRCC5 THOC5 C6orf132 NEFM MSH6 SLC16A1 SMARCA2 FIP1L1 LAS1L SF3B2 DYNC1H1 AHNAK2 | 1.42e-04 | 1450 | 104 | 19 | int:CIT |
| Interaction | TNIP1 interactions | NOLC1 NOP56 TCOF1 BCLAF1 PPP1R12B AHCTF1 ZCCHC17 XRCC5 NEFM TXLNA SLC16A1 BASP1 CLTB FIP1L1 LAS1L SF3B2 DYNC1H1 | 1.57e-04 | 1217 | 104 | 17 | int:TNIP1 |
| Interaction | ZC3H18 interactions | NOLC1 NOP56 TCOF1 BCLAF1 NTRK1 XRCC5 MRPS22 THOC5 ZC3H11A SLC16A1 FIP1L1 TLN2 SPEN SF3B2 | 1.64e-04 | 877 | 104 | 14 | int:ZC3H18 |
| Interaction | SENP3 interactions | 1.68e-04 | 301 | 104 | 8 | int:SENP3 | |
| Interaction | AR interactions | DCAF6 KDM4C TOM1 ZMYND8 HECTD4 SREBF1 RREB1 XRCC5 RRM2 KMT2D ARID5B SMARCA2 USP54 SF3B2 DYNC1H1 | 1.71e-04 | 992 | 104 | 15 | int:AR |
| Interaction | PLCB3 interactions | 1.78e-04 | 101 | 104 | 5 | int:PLCB3 | |
| Interaction | FUBP1 interactions | 2.01e-04 | 309 | 104 | 8 | int:FUBP1 | |
| Interaction | DCPS interactions | NOP56 NTRK1 AHCTF1 XRCC5 C6orf132 SMARCA2 LAS1L SF3B2 DYNC1H1 | 2.04e-04 | 394 | 104 | 9 | int:DCPS |
| Interaction | KIF21A interactions | 2.13e-04 | 105 | 104 | 5 | int:KIF21A | |
| Interaction | YWHAE interactions | NOLC1 TICRR RAPGEF6 MAP1B PPFIBP1 NTRK1 SAMD4B CNTLN C6orf132 ZNF750 ZNF106 MAP7D1 USP54 SPINDOC FGD6 SF3B2 DYNC1H1 | 2.29e-04 | 1256 | 104 | 17 | int:YWHAE |
| Interaction | SUMO2 interactions | ZMYND8 RREB1 XRCC5 MSH6 ZC3H11A BASP1 LAS1L FKBP3 SF3B2 DYNC1H1 AHNAK2 | 2.38e-04 | 591 | 104 | 11 | int:SUMO2 |
| Interaction | RNF31 interactions | 2.41e-04 | 403 | 104 | 9 | int:RNF31 | |
| Interaction | AIM2 interactions | 2.65e-04 | 110 | 104 | 5 | int:AIM2 | |
| Interaction | BCR interactions | 2.74e-04 | 244 | 104 | 7 | int:BCR | |
| Interaction | NAA11 interactions | 2.97e-04 | 62 | 104 | 4 | int:NAA11 | |
| Interaction | SNIP1 interactions | 3.10e-04 | 417 | 104 | 9 | int:SNIP1 | |
| Interaction | SRPK2 interactions | NOLC1 NOP56 TCOF1 BCLAF1 NTRK1 ZCCHC17 XRCC5 SCAF4 MAP7D1 FIP1L1 LAS1L SPEN | 3.25e-04 | 717 | 104 | 12 | int:SRPK2 |
| Interaction | SOX2 interactions | NOP56 MAP1B BCLAF1 SAMD4B TOM1 ZMYND8 CHD9 CNTLN XRCC5 MRPS22 MSH6 ARHGEF40 KMT2D ARID5B SMARCA2 FIP1L1 LAS1L SPEN | 3.32e-04 | 1422 | 104 | 18 | int:SOX2 |
| Interaction | MOV10 interactions | NOLC1 DCAF6 RAPGEF6 HYOU1 NOP56 MAP1B KDM4C BCLAF1 PPFIBP1 NTRK1 AHCTF1 SAMD4B AGGF1 SMG5 CEP164 TXLNA PLCB3 | 3.33e-04 | 1297 | 104 | 17 | int:MOV10 |
| Interaction | PAGE4 interactions | 3.41e-04 | 253 | 104 | 7 | int:PAGE4 | |
| Interaction | BRD9 interactions | 3.52e-04 | 117 | 104 | 5 | int:BRD9 | |
| Interaction | PRKCSH interactions | 3.75e-04 | 257 | 104 | 7 | int:PRKCSH | |
| Interaction | GIPC1 interactions | 3.81e-04 | 119 | 104 | 5 | int:GIPC1 | |
| Interaction | DLD interactions | NOLC1 HYOU1 MAP1B BCLAF1 NTRK1 XRCC5 MRPS22 MICALL2 CLTB CACYBP | 3.92e-04 | 526 | 104 | 10 | int:DLD |
| Interaction | YWHAZ interactions | NOLC1 TICRR RAPGEF6 TEX2 PPFIBP1 NTRK1 SAMD4B HECTD4 CNKSR2 C6orf132 NEFM TXLNA MAP7D1 USP54 FGD6 SF3B2 DYNC1H1 | 4.04e-04 | 1319 | 104 | 17 | int:YWHAZ |
| Interaction | EFTUD2 interactions | NOLC1 NOP56 TCOF1 PPFIBP1 NTRK1 XRCC5 MRPS22 MSH6 TXLNA MAP7D1 BASP1 SMARCA2 PLCB3 CACYBP FKBP3 SF3B2 DYNC1H1 AHNAK2 | 4.17e-04 | 1449 | 104 | 18 | int:EFTUD2 |
| Interaction | SNRNP40 interactions | NOP56 TCOF1 BCLAF1 AHCTF1 AGGF1 GON4L SCAF4 PRPF40B LAS1L SPEN NPAT | 4.49e-04 | 637 | 104 | 11 | int:SNRNP40 |
| Interaction | HNF1B interactions | 4.58e-04 | 190 | 104 | 6 | int:HNF1B | |
| Interaction | BIRC3 interactions | NOLC1 HYOU1 NOP56 TCOF1 BCLAF1 XRCC5 PRDM2 MSH6 TXLNA ZC3H11A SLC16A1 TLN2 CACYBP SPEN FKBP3 SF3B2 DYNC1H1 | 4.60e-04 | 1334 | 104 | 17 | int:BIRC3 |
| Interaction | NXF1 interactions | NOLC1 DCAF6 RAPGEF6 HYOU1 NOP56 MAP1B KDM4C BCLAF1 PPFIBP1 AHCTF1 AGGF1 SMG5 THOC5 ZNF106 TXLNA ZC3H11A PLCB3 | 5.05e-04 | 1345 | 104 | 17 | int:NXF1 |
| Interaction | HDAC2 interactions | NTRK1 ZMYND8 ZFPM1 RREB1 HM13 XRCC5 TXLNA ARID5B SMARCA2 SPEN FKBP3 DYNC1H1 AHNAK2 | 5.07e-04 | 865 | 104 | 13 | int:HDAC2 |
| Interaction | TNK2 interactions | 5.25e-04 | 195 | 104 | 6 | int:TNK2 | |
| Interaction | HECTD1 interactions | NOLC1 TICRR NOP56 MAP1B SREBF1 AGGF1 ZCCHC17 XRCC5 MRPS22 MSH6 TXLNA ZC3H11A LAS1L FKBP3 | 5.27e-04 | 984 | 104 | 14 | int:HECTD1 |
| Interaction | MECOM interactions | 5.37e-04 | 358 | 104 | 8 | int:MECOM | |
| Interaction | RPA4 interactions | STRN3 RAPGEF6 TCOF1 BCLAF1 AHCTF1 SLC16A1 CACYBP LAS1L SF3B2 | 5.55e-04 | 452 | 104 | 9 | int:RPA4 |
| Interaction | NDN interactions | 5.64e-04 | 453 | 104 | 9 | int:NDN | |
| Interaction | COIL interactions | 5.70e-04 | 552 | 104 | 10 | int:COIL | |
| Interaction | ARRB2 interactions | 5.73e-04 | 454 | 104 | 9 | int:ARRB2 | |
| Interaction | LLGL2 interactions | 6.33e-04 | 133 | 104 | 5 | int:LLGL2 | |
| Interaction | NAA16 interactions | 6.51e-04 | 33 | 104 | 3 | int:NAA16 | |
| Interaction | DNAJC17 interactions | 6.55e-04 | 134 | 104 | 5 | int:DNAJC17 | |
| Interaction | SLC35G1 interactions | 7.11e-04 | 34 | 104 | 3 | int:SLC35G1 | |
| Interaction | PNKP interactions | 7.24e-04 | 137 | 104 | 5 | int:PNKP | |
| Interaction | DDX39B interactions | BCLAF1 NTRK1 SREBF1 HM13 XRCC5 THOC5 ZC3H11A BASP1 SF3B2 DYNC1H1 | 7.30e-04 | 570 | 104 | 10 | int:DDX39B |
| Interaction | SF3A1 interactions | 7.44e-04 | 471 | 104 | 9 | int:SF3A1 | |
| Interaction | KRT222 interactions | 7.75e-04 | 35 | 104 | 3 | int:KRT222 | |
| Interaction | MIER1 interactions | 7.83e-04 | 80 | 104 | 4 | int:MIER1 | |
| GeneFamily | PWWP domain containing | 5.12e-05 | 22 | 60 | 3 | 1147 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.43e-03 | 17 | 60 | 2 | 1197 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.79e-03 | 19 | 60 | 2 | 832 | |
| GeneFamily | Sterile alpha motif domain containing | 3.12e-03 | 88 | 60 | 3 | 760 | |
| GeneFamily | PHD finger proteins | 3.33e-03 | 90 | 60 | 3 | 88 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NOLC1 STRN3 BCLAF1 ZMYND8 GON4L CHD9 TXLNA MAP7D1 ARID5B SMARCA2 SF3B2 | 2.34e-06 | 467 | 103 | 11 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NOLC1 STRN3 BCLAF1 ZMYND8 GON4L CHD9 TXLNA MAP7D1 ARID5B SMARCA2 SF3B2 | 3.29e-06 | 484 | 103 | 11 | MM999 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STRN3 MAP1B KDM4C AHCTF1 ZMYND8 CHD9 AZIN1 MALT1 MSH6 ARID5B SMARCA2 MICAL3 SPEN NPAT | 6.57e-06 | 856 | 103 | 14 | M4500 |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 2.17e-05 | 85 | 103 | 5 | M41085 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | NOLC1 DCAF6 NOP56 ZMYND8 SREBF1 FAM114A2 XRCC5 RRM2 MRPS22 MSH6 MICALL2 TLN2 FHDC1 CACYBP LAS1L FKBP3 | 3.56e-05 | 1271 | 103 | 16 | M39197 |
| Coexpression | IBRAHIM_NRF1_UP | NOLC1 HYOU1 SAMD4B SMG5 MRPS22 MAP7D1 ZC3H11A SLC16A1 CACYBP | 4.25e-05 | 420 | 103 | 9 | M42509 |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 7.24e-05 | 177 | 103 | 6 | M9401 | |
| Coexpression | HALLMARK_MYC_TARGETS_V2 | 8.11e-05 | 58 | 103 | 4 | M5928 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPGEF6 ANK2 MAP1B PPFIBP1 ZMYND8 FAM114A2 AMER3 PRDM2 BASP1 TLN2 MICAL3 ANKRD36 AHNAK2 ARMH4 | 1.08e-04 | 1106 | 103 | 14 | M39071 |
| Coexpression | FISCHER_DREAM_TARGETS | NOLC1 TICRR RAPGEF6 TCOF1 BCLAF1 AHCTF1 RRM2 AZIN1 MSH6 SLC16A1 CACYBP LAS1L NPAT | 1.10e-04 | 969 | 103 | 13 | M149 |
| Coexpression | TOOKER_GEMCITABINE_RESISTANCE_DN | 1.27e-04 | 123 | 103 | 5 | M18806 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 1.38e-04 | 199 | 103 | 6 | M9498 | |
| Coexpression | GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP | 1.38e-04 | 199 | 103 | 6 | M8223 | |
| Coexpression | GSE3982_MAST_CELL_VS_NEUTROPHIL_UP | 1.38e-04 | 199 | 103 | 6 | M5432 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN | 1.40e-04 | 384 | 103 | 8 | M12527 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 1.42e-04 | 200 | 103 | 6 | M4817 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOLC1 TICRR ANK2 NOP56 UNCX MAP1B TCOF1 BCLAF1 AHCTF1 DAB1 CHD9 ZCCHC17 CNTLN RRM2 MRPS22 NEFM MSH6 SLC16A1 BASP1 FIP1L1 CACYBP FKBP3 | 1.82e-06 | 1459 | 104 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NOLC1 TICRR ANK2 NOP56 TCOF1 BCLAF1 AHCTF1 DAB1 CHD9 ZCCHC17 CNTLN RRM2 MRPS22 MSH6 SLC16A1 BASP1 FIP1L1 CACYBP FKBP3 | 1.00e-05 | 1257 | 104 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | MAP1B BCLAF1 PPP1R12B BCAS1 ZNF106 ZC3H11A ARID5B SMARCA2 ANKRD36 | 1.03e-09 | 199 | 104 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.00e-07 | 188 | 104 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 4.56e-07 | 200 | 104 | 7 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 4.56e-07 | 200 | 104 | 7 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 173 | 104 | 6 | a8fb8db6061fa4d8d56a7b45004ecbd344501573 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 178 | 104 | 6 | 9c4950357087212b2388116ba8866c359628694d | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.84e-06 | 185 | 104 | 6 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-06 | 187 | 104 | 6 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.35e-06 | 194 | 104 | 6 | f0c113edb706d53792892115b67277a285219942 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.35e-06 | 194 | 104 | 6 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | Influenza-Influenza_Severe-Others-RBC|Influenza_Severe / Disease, condition lineage and cell class | 7.35e-06 | 199 | 104 | 6 | da0fec0a492bc3827d9066d2590bcd466cd45564 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 7.35e-06 | 199 | 104 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-05 | 162 | 104 | 5 | 08ee7ae56e4927874515c47adc86dd845bf29a26 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-05 | 167 | 104 | 5 | 3461d14e36f09ddc6ee5549ca4797e16d3f37fcc | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 168 | 104 | 5 | 17fb9426eeea407b26fb895b8397faca95b7552d | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 168 | 104 | 5 | a61b39884851384cffd430079040546d125b2b40 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 173 | 104 | 5 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | severe-B_memory|severe / disease stage, cell group and cell class | 5.36e-05 | 173 | 104 | 5 | 3a987ac53a0136cc4c70ce8b901a15fc00c795e1 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 173 | 104 | 5 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-05 | 175 | 104 | 5 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-05 | 175 | 104 | 5 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | severe-B_memory|World / disease stage, cell group and cell class | 5.82e-05 | 176 | 104 | 5 | 4e5c6b1aa5ffd13593a6bcd1e1253c1737c5c2b4 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 177 | 104 | 5 | e5070934c674a46e070b0d52b9a374516bf6aea1 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 177 | 104 | 5 | b37d821f4f3204daf7c568ac17a0af0ba97273d6 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 178 | 104 | 5 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-05 | 180 | 104 | 5 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.47e-05 | 180 | 104 | 5 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | normal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.82e-05 | 182 | 104 | 5 | ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.00e-05 | 183 | 104 | 5 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.18e-05 | 184 | 104 | 5 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-05 | 186 | 104 | 5 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 7.75e-05 | 187 | 104 | 5 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 187 | 104 | 5 | 99724aa3dbdcb073ea3bfe80cc825ecae5495db8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.75e-05 | 187 | 104 | 5 | 2a7226adb4d15b92936603bdf05421c50b21f003 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.15e-05 | 189 | 104 | 5 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 8.15e-05 | 189 | 104 | 5 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.35e-05 | 190 | 104 | 5 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 8.35e-05 | 190 | 104 | 5 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-05 | 191 | 104 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-05 | 191 | 104 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-05 | 191 | 104 | 5 | 08be56a4055a73c920d345fd3b2052a5ccb675d8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-05 | 191 | 104 | 5 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-05 | 191 | 104 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.99e-05 | 193 | 104 | 5 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.99e-05 | 193 | 104 | 5 | ac227ddabfb3f021b1b39dba73f898517cd5a58e | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.99e-05 | 193 | 104 | 5 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 8.99e-05 | 193 | 104 | 5 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.21e-05 | 194 | 104 | 5 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 9.21e-05 | 194 | 104 | 5 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.21e-05 | 194 | 104 | 5 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|CTRL / Disease state, Lineage and Cell class | 9.21e-05 | 194 | 104 | 5 | 927480f56cccd3940b689f3c40ee132fe3e63745 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 9.21e-05 | 194 | 104 | 5 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | ASK452-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.44e-05 | 195 | 104 | 5 | 20f492299a684ac1b7dd1bbc36a533cd6f9a1c93 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.44e-05 | 195 | 104 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | COVID-19_Severe-B_memory|COVID-19_Severe / disease group, cell group and cell class | 9.44e-05 | 195 | 104 | 5 | 54becd9e283639638fc5f13eddce224aed9391da | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.44e-05 | 195 | 104 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.44e-05 | 195 | 104 | 5 | 1daddd801bd4596fffbdb822fc326d5127c96004 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.44e-05 | 195 | 104 | 5 | 01a750d660993017af00736215cbcff2de5909c1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.44e-05 | 195 | 104 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.67e-05 | 196 | 104 | 5 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Myelocyte-like|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.67e-05 | 196 | 104 | 5 | 4b88c96b737a747422674ad99c073b28e6febc7c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 9.67e-05 | 196 | 104 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 9.67e-05 | 196 | 104 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 9.67e-05 | 196 | 104 | 5 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.90e-05 | 197 | 104 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.90e-05 | 197 | 104 | 5 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 9.90e-05 | 197 | 104 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.01e-04 | 198 | 104 | 5 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.01e-04 | 198 | 104 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 1.01e-04 | 198 | 104 | 5 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.04e-04 | 199 | 104 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_naive|Influenza_Severe / Disease, condition lineage and cell class | 1.06e-04 | 200 | 104 | 5 | 0e05600d725dc5cc9afccc11eedc60efa41e4e46 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.06e-04 | 200 | 104 | 5 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.06e-04 | 200 | 104 | 5 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-04 | 200 | 104 | 5 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B|Influenza_Severe / Disease, condition lineage and cell class | 1.06e-04 | 200 | 104 | 5 | bf238a0a074d6c5cba8cb73d3b715ee701a612b6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Cortical_neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-04 | 200 | 104 | 5 | 6f7ff0533339fcc9d316f2c77334a79c1409ec4f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-04 | 124 | 104 | 4 | e9b6fdac2bef4bf1fee6a486f4628b68adc80f57 | |
| Drug | benz(a)anthracene | SLC2A9 TCOF1 BCLAF1 PPFIBP1 ZMYND8 GON4L CLSTN2 HM13 RRM2 AZIN1 MALT1 TXLNA ARHGEF40 PRPF40B PLCB1 TLN2 EML1 CACYBP FGD6 AHNAK2 | 6.01e-07 | 1251 | 102 | 20 | ctd:C030935 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.69e-05 | 180 | 102 | 7 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.81e-05 | 182 | 102 | 7 | 3887_DN | |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | 2.39e-05 | 190 | 102 | 7 | 1103_UP | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 5736_DN | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; HL60; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 3040_DN | |
| Drug | Arecoline hydrobromide [300-08-3]; Down 200; 17uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 2657_DN | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 7422_DN | |
| Drug | CP-944629 [668990-94-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.32e-05 | 200 | 102 | 7 | 7544_DN | |
| Drug | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | NOLC1 NOP56 TCOF1 BCLAF1 NTRK1 RRM2 ZNF750 MSH6 ARID5B CACYBP AHNAK2 | 3.39e-05 | 546 | 102 | 11 | ctd:C532162 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.73e-05 | 45 | 101 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | Diffuse Large B-Cell Lymphoma | 3.86e-05 | 55 | 101 | 4 | C0079744 | |
| Disease | white matter hyperintensity measurement | 8.30e-05 | 302 | 101 | 7 | EFO_0005665 | |
| Disease | chronic kidney disease | 1.61e-04 | 235 | 101 | 6 | EFO_0003884 | |
| Disease | blood urea nitrogen measurement | 1.66e-04 | 452 | 101 | 8 | EFO_0004741 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 1.72e-04 | 6 | 101 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | hyperuricemia | 1.97e-04 | 33 | 101 | 3 | EFO_0009104 | |
| Disease | Headache, HOMA-B | 2.41e-04 | 7 | 101 | 2 | EFO_0004469, HP_0002315 | |
| Disease | uric acid measurement | 2.51e-04 | 610 | 101 | 9 | EFO_0004761 | |
| Disease | hoarding disorder | 2.56e-04 | 36 | 101 | 3 | EFO_0803361 | |
| Disease | neuroimaging measurement | STRN3 MAP1B DAB1 CNKSR2 RREB1 RGP1 NEFM ZNF106 SMARCA2 TLN2 EML1 FGD6 | 2.95e-04 | 1069 | 101 | 12 | EFO_0004346 |
| Disease | body surface area | 3.69e-04 | 643 | 101 | 9 | EFO_0022196 | |
| Disease | synaptotagmin-11 measurement | 4.11e-04 | 9 | 101 | 2 | EFO_0802108 | |
| Disease | diastolic blood pressure, systolic blood pressure | 4.96e-04 | 670 | 101 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | lactose measurement | 5.13e-04 | 10 | 101 | 2 | EFO_0010507 | |
| Disease | cortical surface area measurement | TICRR STRN3 PPFIBP1 PPP1R12B SREBF1 DAB1 CNTLN RREB1 RGP1 ZNF106 TLN2 EML1 FGD6 | 6.79e-04 | 1345 | 101 | 13 | EFO_0010736 |
| Disease | Duchenne muscular dystrophy, disease progression measurement | 6.79e-04 | 50 | 101 | 3 | EFO_0008336, MONDO_0010679 | |
| Disease | hematocrit | BRPF3 UNCX HECTD4 SREBF1 ZFPM1 RREB1 CEP164 ARHGEF40 MICALL2 PLCB1 PLCB3 | 6.92e-04 | 1011 | 101 | 11 | EFO_0004348 |
| Disease | Colorectal Carcinoma | 6.92e-04 | 702 | 101 | 9 | C0009402 | |
| Disease | coronary artery disease | MAP1B PPP1R12B HECTD4 SREBF1 DAB1 CNKSR2 ZFPM1 ZC3H11A BASP1 SLC18A1 EML1 FGD6 | 7.88e-04 | 1194 | 101 | 12 | EFO_0001645 |
| Disease | Ischemic stroke, fibrinogen measurement | 8.97e-04 | 55 | 101 | 3 | EFO_0004623, HP_0002140 | |
| Disease | bitter alcoholic beverage consumption measurement | 1.15e-03 | 133 | 101 | 4 | EFO_0010092 | |
| Disease | T-Cell Lymphoma | 1.35e-03 | 16 | 101 | 2 | C0079772 | |
| Disease | breast carcinoma (is_marker_for) | 1.52e-03 | 66 | 101 | 3 | DOID:3459 (is_marker_for) | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 1.53e-03 | 17 | 101 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.59e-03 | 67 | 101 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | photoreceptor cell layer thickness measurement | 1.70e-03 | 148 | 101 | 4 | EFO_0803370 | |
| Disease | renal system measurement | 2.12e-03 | 20 | 101 | 2 | EFO_0004742 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 2.56e-03 | 22 | 101 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | cystatin C measurement | 2.63e-03 | 402 | 101 | 6 | EFO_0004617 | |
| Disease | pulse pressure measurement | BRPF3 ANK2 MAP1B TEX2 RREB1 CEP164 PRDM11 PRPF40B TLN2 EML1 SPINDOC FGD6 | 2.86e-03 | 1392 | 101 | 12 | EFO_0005763 |
| Disease | brain measurement, neuroimaging measurement | 2.87e-03 | 550 | 101 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | visceral adipose tissue measurement, body mass index | 3.35e-03 | 87 | 101 | 3 | EFO_0004340, EFO_0004765 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSPGLEEDKKEAESP | 391 | Q8N944 | |
| EEDKKEAESPGTPAA | 396 | Q8N944 | |
| PEPDSVFKTEQSEDK | 271 | O43315 | |
| VKEEYEGSGKPESEP | 431 | Q8TER5 | |
| PTEDGKDQKESDPTE | 896 | Q9NXG0 | |
| DKFPSGVEKTGSDEP | 296 | O14977 | |
| SGKTEEEKEDPSPVS | 491 | Q86TY3 | |
| PDEEDKGEKEGSTVP | 481 | Q9NPY3 | |
| IKKEPEEAGQDTPST | 456 | Q9ULD4 | |
| DESFVGPTLSKEEKE | 541 | Q8N302 | |
| QKPPALKGTSDEEDS | 956 | A6QL64 | |
| PEESASSEKAKEPET | 596 | Q58WW2 | |
| TEAPGDVKTTDPKSE | 671 | Q9H4D0 | |
| SEDDEAPSKPAGTTK | 371 | Q14978 | |
| DEPKENGSTEEEKPS | 231 | Q9UPP5 | |
| LGKKSEETTVPFPEE | 1036 | Q14207 | |
| EKEGKDIPPDETQST | 1676 | Q01484 | |
| EGQEKTTDEPTEPGK | 166 | Q5HY64 | |
| VKGDPEDAAPKDSST | 1071 | Q9C0D6 | |
| AESPDQKDTDGGPKE | 481 | P53985 | |
| NSTSGDPVEKKDETP | 401 | P04629 | |
| DPVEKKDETPFGVSV | 406 | P04629 | |
| KFSKEEPVSSGPEEA | 561 | O00567 | |
| KSEEELEASKSFGPG | 976 | Q7RTP6 | |
| ESPFEEKSGKQGSPD | 1426 | P46821 | |
| IDPKDANKGTPEETG | 641 | Q9UDY8 | |
| AKEGVPSEGPETKVE | 416 | Q8NI17 | |
| KLTPKPETSFEENDG | 426 | Q86W92 | |
| EAPKAEPEKTEGAAE | 81 | P80723 | |
| EPEKTEGAAEAKAEP | 86 | P80723 | |
| ASEDSEEEPSGKKAP | 121 | Q8IY33 | |
| KEKPSYDTETDPSEG | 176 | Q9HB71 | |
| NGVPKPKVTETEDDS | 71 | Q6UN15 | |
| GSPAAAATDEKPKET | 271 | Q8IX07 | |
| SSGYEKPEKSDPSEL | 491 | Q9H3R0 | |
| KPEPQDDGKSTESDV | 226 | Q9Y4W2 | |
| PKDPAAVTESKEGTE | 351 | Q8TCT9 | |
| DSEGKSEDEPDTIPT | 2711 | Q9Y4D8 | |
| SDIGGSDVEFKPDTK | 256 | P52701 | |
| EQTDPKKPTTDEGTA | 566 | Q01970 | |
| TPSVPDDFADKEVTG | 96 | Q5T0Z8 | |
| PENFPTASVEGKEEK | 551 | Q3L8U1 | |
| DPKGKEESFSLESDV | 191 | P52951 | |
| SEAQKPSEKAEAGPE | 661 | Q9Y4L1 | |
| EEPGKAVSSSPDEET | 61 | Q0VDD7 | |
| FESPSKSEEQEAPDG | 546 | O75553 | |
| APEKLAEVGEFDPSK | 226 | Q9BWC9 | |
| SKSQEEPKDTFEHDP | 181 | Q9NYF8 | |
| EETLDEGPPKYTKSV | 101 | Q00688 | |
| TLKEPFSGEPSEEVK | 151 | Q3T8J9 | |
| DEAVGDSAEKPPTFA | 1546 | Q3T8J9 | |
| ESVDQGAKPESKSEP | 31 | Q9NRY5 | |
| KEEAKESPSAAGPED | 511 | Q3KQU3 | |
| KPKVTDFGDKVEDPT | 226 | Q14204 | |
| EGREKTTDEPTEPGK | 281 | Q5JRC9 | |
| YPPEEKIDSAVTDGK | 521 | Q9NRM0 | |
| EKDGDKDVFASEVTP | 1356 | Q8WYP5 | |
| SESKPKEPVFSAEEG | 171 | O00423 | |
| ETKKDPEDTGAEKSP | 301 | O75363 | |
| TSPASEKADPGAVKD | 651 | Q9ULU4 | |
| PAEATSSVEPEKDSG | 1126 | O95104 | |
| AEGPKEDEEKPSASA | 206 | Q13029 | |
| EAAESGSPETKKPTF | 56 | P82650 | |
| FESEETKDTEAPTAP | 151 | Q13033 | |
| ESTPAESSEGLDPKD | 1456 | Q8TEU7 | |
| GKAKPVVSDFDSDEE | 1561 | P51531 | |
| PAFQSDGTDEPESKE | 411 | Q9UPR3 | |
| DGTDEPESKEPVEKE | 416 | Q9UPR3 | |
| SSDETDVEGKPSVKP | 206 | Q13428 | |
| APSSPFLEEDEGGKK | 176 | Q92546 | |
| EEEPSSFKADSPAEA | 416 | Q9NQV5 | |
| SPDADDDSVAKSKPG | 576 | Q9Y6H5 | |
| GPDSKDSPKDREVAE | 286 | Q9BUA3 | |
| DSEPDSPVFEDSKAK | 456 | P36956 | |
| TPKFAFSTEKEPERE | 491 | Q8IVF2 | |
| TGPKVDPECSVEDSK | 4971 | Q8IVF2 | |
| SEKVAEEAGEKGPTP | 526 | Q14865 | |
| GSEPAKASEKEAPED | 336 | Q9UPV0 | |
| EEAFVKESKEETPGT | 176 | P09497 | |
| ESDKEEADTPSTPKQ | 686 | Q8WXI2 | |
| EFESPIPEAKDSSKA | 376 | Q32MQ0 | |
| ESDEDKPDETGFITP | 726 | Q13435 | |
| GKTPSSQSKDPRDED | 1856 | Q7Z2Z1 | |
| EEAKSAEFEKPDPTR | 166 | Q9NP64 | |
| PEKSESPQKEDGLSS | 2121 | Q96T58 | |
| NPATEESGSDSKEPK | 196 | Q9BSU3 | |
| GTDKGTEAKDPPAVE | 431 | Q5PRF9 | |
| KLYPESEEDKEAPTG | 86 | Q03431 | |
| ATPSEAKKPEEEAGS | 951 | Q92766 | |
| AKKPEEEAGSSEQPS | 956 | Q92766 | |
| TEPKTKAAAPGVEDE | 56 | P31350 | |
| DAEEPKGVTSEEFDK | 431 | O60784 | |
| ITPEKPAEEGNDSKG | 111 | O60225 | |
| QPTESSTDPIKEKGD | 71 | Q5MJ08 | |
| STGKPPLSVEDDFEK | 761 | O75152 | |
| FVSSEPGDPEKDTKE | 961 | O94964 | |
| VSSESSKGEPDPLED | 846 | Q6ZV73 | |
| PVQESSTDDKKPGER | 146 | Q9Y6A9 | |
| PESETDPEEKAGKES | 796 | Q6NWY9 | |
| EEVKKEADPGETPSE | 836 | Q9NQ66 | |
| FQSKDVPEKTSSPEE | 2161 | Q9Y4G6 | |
| EGSVDEAKALFKPPE | 291 | Q13769 | |
| TDKETSEEKPPAEGS | 651 | Q8IWB9 | |
| SESGEEKPDSPSKKD | 1441 | Q9H2Y7 | |
| APKDKPSGDTAAVFE | 706 | P13010 | |
| GEKEPSKGDPNTEEI | 131 | P40222 | |
| QPFKLSDSGDPDKES | 86 | A6NJT0 | |
| SEDSAKEFIPDEPSK | 606 | Q70EL1 | |
| KPTKEFPLGEDSDEE | 506 | P54219 | |
| SPDVEPGKEETEESK | 1671 | O14686 | |
| KLTKEIPSPDDGFES | 466 | Q9Y3Q0 | |
| EKPTDTEGLEGSPEK | 676 | O60237 | |
| SPVKATAPEVKEEEG | 511 | P07197 |